1-3 of 3
Renata Boldrini
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma

Free
Ombretta Melaiu, Marco Mina, Marco Chierici, Renata Boldrini, Giuseppe Jurman, Paolo Romania, Valerio D'Alicandro, Maria C. Benedetti, Aurora Castellano, Tao Liu, Cesare Furlanello, Franco Locatelli, Doriana Fruci
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (15): 4462–4472.
https://doi.org/10.1158/1078-0432.CCR-16-2601
Published: 01 August 2017
View articletitled, PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma
Open the PDF for PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients

Free
Sara Cattelani, Raffaella Defferrari, Sonia Marsilio, Rita Bussolari, Olivia Candini, Francesca Corradini, Giovanna Ferrari-Amorotti, Clara Guerzoni, Luisa Pecorari, Chiara Menin, Roberta Bertorelle, Pierluigi Altavista, Heather P. McDowell, Renata Boldrini, Carlo Dominici, Gian Paolo Tonini, Giuseppe Raschellà, Bruno Calabretta
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3248–3253.
https://doi.org/10.1158/1078-0432.CCR-07-4725
Published: 02 June 2008
View articletitled, Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients
Open the PDF for Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients in another window
Journal Articles

Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors

Free
Stefania Uccini, Olga Mannarino, Heather P. McDowell, Ursula Pauser, Roberta Vitali, Pier Giorgio Natali, Pierluigi Altavista, Tiziana Andreano, Simona Coco, Renata Boldrini, Sandro Bosco, Anna Clerico, Denis Cozzi, Alberto Donfrancesco, Alessandro Inserra, George Kokai, Paul D. Losty, Maria R. Nicotra, Giuseppe Raschellà, Gian Paolo Tonini, Carlo Dominici
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 380–389.
https://doi.org/10.1158/1078-0432.380.11.1
Published: 21 January 2005
View articletitled, Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors
Open the PDF for Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors in another window